PL2581387T3 - Przeciwciało monoklonalne anty-Tat HIV-1 - Google Patents
Przeciwciało monoklonalne anty-Tat HIV-1Info
- Publication number
- PL2581387T3 PL2581387T3 PL11306314T PL11306314T PL2581387T3 PL 2581387 T3 PL2581387 T3 PL 2581387T3 PL 11306314 T PL11306314 T PL 11306314T PL 11306314 T PL11306314 T PL 11306314T PL 2581387 T3 PL2581387 T3 PL 2581387T3
- Authority
- PL
- Poland
- Prior art keywords
- monoclonal antibody
- tat hiv
- tat
- hiv
- monoclonal
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—RNA viruses
- C07K16/112—Retroviridae (F), e.g. leukemia viruses
- C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
- C07K16/1147—Regulatory proteins, e.g. trans-activator of transcription [TAT], rev or vacuolar protein targeting [VPT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/33—Crossreactivity, e.g. for species or epitope, or lack of said crossreactivity
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Tropical Medicine & Parasitology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- AIDS & HIV (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11306314.3A EP2581387B1 (en) | 2011-10-11 | 2011-10-11 | An anti-HIV-1 Tat monoclonal antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2581387T3 true PL2581387T3 (pl) | 2016-04-29 |
Family
ID=44862864
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11306314T PL2581387T3 (pl) | 2011-10-11 | 2011-10-11 | Przeciwciało monoklonalne anty-Tat HIV-1 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP2581387B1 (pl) |
| DK (1) | DK2581387T3 (pl) |
| ES (1) | ES2553597T3 (pl) |
| HU (1) | HUE026344T2 (pl) |
| PL (1) | PL2581387T3 (pl) |
| PT (1) | PT2581387E (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105980405A (zh) * | 2013-12-08 | 2016-09-28 | 派特塞尔有限公司 | Hiv抗原和抗体及其组合物、方法和用途 |
| KR20220137698A (ko) * | 2020-02-05 | 2022-10-12 | 라리마 테라퓨틱스, 인코포레이티드 | Tat 펩티드 결합 단백질 및 이의 용도 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4550019A (en) | 1978-03-22 | 1985-10-29 | South Africa Inventions Development Corporation | Manufacture and use of fowl egg antibodies |
| US5750172A (en) | 1987-06-23 | 1998-05-12 | Pharming B.V. | Transgenic non human mammal milk |
| US5633076A (en) | 1989-12-01 | 1997-05-27 | Pharming Bv | Method of producing a transgenic bovine or transgenic bovine embryo |
| US5776427A (en) | 1992-03-05 | 1998-07-07 | Board Of Regents, The University Of Texas System | Methods for targeting the vasculature of solid tumors |
| AU693436B2 (en) | 1993-03-09 | 1998-07-02 | Genzyme Corporation | Isolation of components of interest from milk |
| US5827690A (en) | 1993-12-20 | 1998-10-27 | Genzyme Transgenics Corporatiion | Transgenic production of antibodies in milk |
| WO2006088740A2 (en) * | 2005-02-15 | 2006-08-24 | Thymon, L.L.C. | Methods and compositions for impairing multiplication of hiv-1 |
-
2011
- 2011-10-11 EP EP11306314.3A patent/EP2581387B1/en not_active Not-in-force
- 2011-10-11 PT PT113063143T patent/PT2581387E/pt unknown
- 2011-10-11 ES ES11306314.3T patent/ES2553597T3/es active Active
- 2011-10-11 DK DK11306314.3T patent/DK2581387T3/en active
- 2011-10-11 HU HUE11306314A patent/HUE026344T2/en unknown
- 2011-10-11 PL PL11306314T patent/PL2581387T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE026344T2 (en) | 2016-05-30 |
| ES2553597T3 (es) | 2015-12-10 |
| EP2581387A1 (en) | 2013-04-17 |
| DK2581387T3 (en) | 2015-12-07 |
| PT2581387E (pt) | 2015-12-30 |
| EP2581387B1 (en) | 2015-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES3065861T3 (en) | Interleukin-31 monoclonal antibody | |
| HUS2300021I1 (hu) | Anti-IL-36R antitestek | |
| LT3378535T (lt) | Humanizuoti antikūnai, atpažįstantys alfa-sinukleiną | |
| DK2847231T3 (da) | Multispecifikke monoklonale antistoffer | |
| EP3427721C0 (en) | HIGH CONCENTRATION MONOCLONAL ANTIBODY FORMULATIONS | |
| CO6811812A2 (es) | Anticuerpo anti-b7-h3 | |
| BR112013032552A2 (pt) | variantes de anticorpos monoclonais humanizados imunomoduladores | |
| HUE036663T2 (hu) | Készítmény anti-alfa4béta7 antitesthez | |
| HUE036664T2 (hu) | Készítmény anti-alfa4béta7 antitesthez | |
| CR20140127A (es) | Anticuerpo anti-abtcr | |
| DK2521736T3 (da) | Humaniserede antistoffer | |
| IL229618B (en) | Isolated antibody that binds fcrn | |
| PL3088421T3 (pl) | Przeciwciała monoklonalne do zastosowania w diagnostyce i leczeniu nowotworów i choroby autoimmunologicznej | |
| EP2463368A4 (en) | HUMANIZED ANTIBODIES AGAINST AMYLOID B OLIGOMERS | |
| LT2814843T (lt) | ŽMOGAUS MONOKLONINIAI ANTIKŪNAI, NEUTRALIZUOJANTYS IL-1ß | |
| CO6841994A2 (es) | Anticuerpos | |
| PT2581387E (pt) | Um anticorpo monoclonal tat anti hiv-1 |